APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drugs and Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Contraceptive Drugs and Devices Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchContraceptive Drugs and Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drugs and Devices Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Contraceptive Drugs and Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drugs and Devices Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drugs and Devices Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Drugs and Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Contraceptive Drugs and Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Contraceptive Drugs and Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Contraceptive Drugs and Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Contraceptive Drugs and Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Contraceptive Drugs and Devices include Teva Pharmaceutical Industries, Merck, Pfizer, Bayer Healthcare, Warmer Chilcott, Pantarhei Bioscience, Mayer Laboratories, Church & Dwight and BioSante Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Contraceptive Drugs and Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Contraceptive Drugs and Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptive Drugs and Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contraceptive Drugs and Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contraceptive Drugs and Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Contraceptive Drugs and Devices sales, projected growth trends, production technology, application and end-user industry.

Contraceptive Drugs and Devices Segment by Company

Teva Pharmaceutical Industries

Merck

Pfizer

Bayer Healthcare

Warmer Chilcott

Pantarhei Bioscience

Mayer Laboratories

Church & Dwight

BioSante Pharmaceuticals

Agile Therapeutics

Contraceptive Drugs and Devices Segment by Type

Injectable Contraceptive Drugs

Vaginal

Male/Female Contraceptive Devices

Oral

Contraceptive Drugs and Devices Segment by Application

Hospitals

Pharmacies

Others

Contraceptive Drugs and Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drugs and Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drugs and Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drugs and Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Contraceptive Drugs and Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptive Drugs and Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contraceptive Drugs and Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injectable Contraceptive Drugs Major Manufacturers Table 3. Vaginal Major Manufacturers Table 4. Male/Female Contraceptive Devices Major Manufacturers Table 5. Oral Major Manufacturers Table 6. Global Contraceptive Drugs and Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Pharmacies Major Manufacturers Table 9. Others Major Manufacturers Table 10. Contraceptive Drugs and Devices Industry Trends Table 11. Contraceptive Drugs and Devices Industry Drivers Table 12. Contraceptive Drugs and Devices Industry Opportunities and Challenges Table 13. Contraceptive Drugs and Devices Industry Restraints Table 14. Global Contraceptive Drugs and Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Contraceptive Drugs and Devices Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Contraceptive Drugs and Devices Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2021-2026) Table 18. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2027-2032) Table 19. Global Contraceptive Drugs and Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Contraceptive Drugs and Devices Sales by Region (2021-2026) & (k units) Table 21. Global Contraceptive Drugs and Devices Sales by Region (2027-2032) & (k units) Table 22. Global Contraceptive Drugs and Devices Sales Market Share by Region (2021-2026) Table 23. Global Contraceptive Drugs and Devices Sales Market Share by Region (2027-2032) Table 24. Global Contraceptive Drugs and Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Contraceptive Drugs and Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2021-2026) Table 28. Global Contraceptive Drugs and Devices Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Contraceptive Drugs and Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Contraceptive Drugs and Devices Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Contraceptive Drugs and Devices Manufacturers, Product Type & Application Table 32. Global Contraceptive Drugs and Devices Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Contraceptive Drugs and Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Contraceptive Drugs and Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2026) Table 39. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2027-2032) Table 40. Global Contraceptive Drugs and Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 42. Global Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 43. Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2026) Table 44. Global Contraceptive Drugs and Devices Sales Market Share by Type (2027-2032) Table 45. Global Contraceptive Drugs and Devices Price by Type (2021-2026) & (US$/unit) Table 46. Global Contraceptive Drugs and Devices Price by Type (2027-2032) & (US$/unit) Table 47. Global Contraceptive Drugs and Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2026) Table 51. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2027-2032) Table 52. Global Contraceptive Drugs and Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 54. Global Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 55. Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2026) Table 56. Global Contraceptive Drugs and Devices Sales Market Share by Application (2027-2032) Table 57. Global Contraceptive Drugs and Devices Price by Application (2021-2026) & (US$/unit) Table 58. Global Contraceptive Drugs and Devices Price by Application (2027-2032) & (US$/unit) Table 59. Teva Pharmaceutical Industries Company Information Table 60. Teva Pharmaceutical Industries Business Overview Table 61. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio Table 63. Teva Pharmaceutical Industries Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Merck Contraceptive Drugs and Devices Product Portfolio Table 68. Merck Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Pfizer Contraceptive Drugs and Devices Product Portfolio Table 73. Pfizer Recent Development Table 74. Bayer Healthcare Company Information Table 75. Bayer Healthcare Business Overview Table 76. Bayer Healthcare Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio Table 78. Bayer Healthcare Recent Development Table 79. Warmer Chilcott Company Information Table 80. Warmer Chilcott Business Overview Table 81. Warmer Chilcott Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio Table 83. Warmer Chilcott Recent Development Table 84. Pantarhei Bioscience Company Information Table 85. Pantarhei Bioscience Business Overview Table 86. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio Table 88. Pantarhei Bioscience Recent Development Table 89. Mayer Laboratories Company Information Table 90. Mayer Laboratories Business Overview Table 91. Mayer Laboratories Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio Table 93. Mayer Laboratories Recent Development Table 94. Church & Dwight Company Information Table 95. Church & Dwight Business Overview Table 96. Church & Dwight Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Church & Dwight Contraceptive Drugs and Devices Product Portfolio Table 98. Church & Dwight Recent Development Table 99. BioSante Pharmaceuticals Company Information Table 100. BioSante Pharmaceuticals Business Overview Table 101. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio Table 103. BioSante Pharmaceuticals Recent Development Table 104. Agile Therapeutics Company Information Table 105. Agile Therapeutics Business Overview Table 106. Agile Therapeutics Contraceptive Drugs and Devices Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio Table 108. Agile Therapeutics Recent Development Table 109. North America Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 112. North America Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 113. North America Contraceptive Drugs and Devices Sales Price by Type (2021-2026) & (US$/unit) Table 114. North America Contraceptive Drugs and Devices Sales Price by Type (2027-2032) & (US$/unit) Table 115. North America Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 118. North America Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 119. North America Contraceptive Drugs and Devices Sales Price by Application (2021-2026) & (US$/unit) Table 120. North America Contraceptive Drugs and Devices Sales Price by Application (2027-2032) & (US$/unit) Table 121. North America Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Contraceptive Drugs and Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 125. North America Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 126. North America Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 127. North America Contraceptive Drugs and Devices Sales Price by Country (2021-2026) & (US$/unit) Table 128. North America Contraceptive Drugs and Devices Sales Price by Country (2027-2032) & (US$/unit) Table 129. United States Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 130. Canada Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 131. Mexico Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 132. Europe Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 135. Europe Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 136. Europe Contraceptive Drugs and Devices Sales Price by Type (2021-2026) & (US$/unit) Table 137. Europe Contraceptive Drugs and Devices Sales Price by Type (2027-2032) & (US$/unit) Table 138. Europe Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 141. Europe Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 142. Europe Contraceptive Drugs and Devices Sales Price by Application (2021-2026) & (US$/unit) Table 143. Europe Contraceptive Drugs and Devices Sales Price by Application (2027-2032) & (US$/unit) Table 144. Europe Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Europe Contraceptive Drugs and Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Europe Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Europe Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 149. Europe Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 150. Europe Contraceptive Drugs and Devices Sales Price by Country (2021-2026) & (US$/unit) Table 151. Europe Contraceptive Drugs and Devices Sales Price by Country (2027-2032) & (US$/unit) Table 152. Germany Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 153. France Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 154. U.K. Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 155. Italy Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 156. Russia Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 157. Spain Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 159. Switzerland Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 160. Sweden Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 161. Poland Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 162. China Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (US$ Million) Table 163. China Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (US$ Million) Table 164. China Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 165. China Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 166. China Contraceptive Drugs and Devices Sales Price by Type (2021-2026) & (US$/unit) Table 167. China Contraceptive Drugs and Devices Sales Price by Type (2027-2032) & (US$/unit) Table 168. China Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (US$ Million) Table 169. China Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (US$ Million) Table 170. China Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 171. China Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 172. China Contraceptive Drugs and Devices Sales Price by Application (2021-2026) & (US$/unit) Table 173. China Contraceptive Drugs and Devices Sales Price by Application (2027-2032) & (US$/unit) Table 174. Asia Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 177. Asia Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 178. Asia Contraceptive Drugs and Devices Sales Price by Type (2021-2026) & (US$/unit) Table 179. Asia Contraceptive Drugs and Devices Sales Price by Type (2027-2032) & (US$/unit) Table 180. Asia Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 183. Asia Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 184. Asia Contraceptive Drugs and Devices Sales Price by Application (2021-2026) & (US$/unit) Table 185. Asia Contraceptive Drugs and Devices Sales Price by Application (2027-2032) & (US$/unit) Table 186. Asia Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Asia Contraceptive Drugs and Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Asia Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 190. Asia Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 191. Asia Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 192. Asia Contraceptive Drugs and Devices Sales Price by Country (2021-2026) & (US$/unit) Table 193. Asia Contraceptive Drugs and Devices Sales Price by Country (2027-2032) & (US$/unit) Table 194. Japan Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 195. South Korea Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 196. India Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 197. Australia Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 198. Taiwan Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 199. Southeast Asia Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 200. SAMEA Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (US$ Million) Table 201. SAMEA Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (US$ Million) Table 202. SAMEA Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 203. SAMEA Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 204. SAMEA Contraceptive Drugs and Devices Sales Price by Type (2021-2026) & (US$/unit) Table 205. SAMEA Contraceptive Drugs and Devices Sales Price by Type (2027-2032) & (US$/unit) Table 206. SAMEA Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (US$ Million) Table 207. SAMEA Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (US$ Million) Table 208. SAMEA Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 209. SAMEA Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 210. SAMEA Contraceptive Drugs and Devices Sales Price by Application (2021-2026) & (US$/unit) Table 211. SAMEA Contraceptive Drugs and Devices Sales Price by Application (2027-2032) & (US$/unit) Table 212. SAMEA Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. SAMEA Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. SAMEA Contraceptive Drugs and Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. SAMEA Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 216. SAMEA Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 217. SAMEA Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 218. SAMEA Contraceptive Drugs and Devices Sales Price by Country (2021-2026) & (US$/unit) Table 219. SAMEA Contraceptive Drugs and Devices Sales Price by Country (2027-2032) & (US$/unit) Table 220. Brazil Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 221. Argentina Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 222. Chile Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 223. Colombia Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 224. Peru Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 225. Saudi Arabia Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 226. Israel Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 227. UAE Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 228. Turkey Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 229. Iran Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 230. Egypt Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Contraceptive Drugs and Devices Distributors List Table 234. Contraceptive Drugs and Devices Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Contraceptive Drugs and Devices Image Figure 2. Global Contraceptive Drugs and Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drugs and Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injectable Contraceptive Drugs Image Figure 5. Vaginal Image Figure 6. Male/Female Contraceptive Devices Image Figure 7. Oral Image Figure 8. Global Contraceptive Drugs and Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Contraceptive Drugs and Devices Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Pharmacies Image Figure 12. Others Image Figure 13. Global Contraceptive Drugs and Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Figure 15. Global Contraceptive Drugs and Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Contraceptive Drugs and Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2021-2032) Figure 18. Global Contraceptive Drugs and Devices Sales (2021-2032) & (k units) Figure 19. Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Contraceptive Drugs and Devices Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Contraceptive Drugs and Devices Sales YoY (2021-2032) & (k units) Figure 22. Europe Contraceptive Drugs and Devices Sales YoY (2021-2032) & (k units) Figure 23. China Contraceptive Drugs and Devices Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Contraceptive Drugs and Devices Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Contraceptive Drugs and Devices Sales YoY (2021-2032) & (k units) Figure 26. Global Contraceptive Drugs and Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Contraceptive Drugs and Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Contraceptive Drugs and Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Contraceptive Drugs and Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2032) Figure 32. Global Contraceptive Drugs and Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Contraceptive Drugs and Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2032) Figure 35. Global Contraceptive Drugs and Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Contraceptive Drugs and Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2032) Figure 38. Global Contraceptive Drugs and Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Contraceptive Drugs and Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2032) Figure 41. North America Contraceptive Drugs and Devices Revenue Share by Type (2021-2032) Figure 42. North America Contraceptive Drugs and Devices Sales Share by Type (2021-2032) Figure 43. North America Contraceptive Drugs and Devices Revenue Share by Application (2021-2032) Figure 44. North America Contraceptive Drugs and Devices Sales Share by Application (2021-2032) Figure 45. North America Contraceptive Drugs and Devices Revenue Share by Country (2021-2032) Figure 46. North America Contraceptive Drugs and Devices Sales Share by Country (2021-2032) Figure 47. Europe Contraceptive Drugs and Devices Revenue Share by Type (2021-2032) Figure 48. Europe Contraceptive Drugs and Devices Sales Share by Type (2021-2032) Figure 49. Europe Contraceptive Drugs and Devices Revenue Share by Application (2021-2032) Figure 50. Europe Contraceptive Drugs and Devices Sales Share by Application (2021-2032) Figure 51. Europe Contraceptive Drugs and Devices Revenue Share by Country (2021-2032) Figure 52. Europe Contraceptive Drugs and Devices Sales Share by Country (2021-2032) Figure 53. China Contraceptive Drugs and Devices Revenue Share by Type (2021-2032) Figure 54. China Contraceptive Drugs and Devices Sales Share by Type (2021-2032) Figure 55. China Contraceptive Drugs and Devices Revenue Share by Application (2021-2032) Figure 56. China Contraceptive Drugs and Devices Sales Share by Application (2021-2032) Figure 57. Asia Contraceptive Drugs and Devices Revenue Share by Type (2021-2032) Figure 58. Asia Contraceptive Drugs and Devices Sales Share by Type (2021-2032) Figure 59. Asia Contraceptive Drugs and Devices Revenue Share by Application (2021-2032) Figure 60. Asia Contraceptive Drugs and Devices Sales Share by Application (2021-2032) Figure 61. Asia Contraceptive Drugs and Devices Revenue Share by Country (2021-2032) Figure 62. Asia Contraceptive Drugs and Devices Sales Share by Country (2021-2032) Figure 63. SAMEA Contraceptive Drugs and Devices Revenue Share by Type (2021-2032) Figure 64. SAMEA Contraceptive Drugs and Devices Sales Share by Type (2021-2032) Figure 65. SAMEA Contraceptive Drugs and Devices Revenue Share by Application (2021-2032) Figure 66. SAMEA Contraceptive Drugs and Devices Sales Share by Application (2021-2032) Figure 67. SAMEA Contraceptive Drugs and Devices Revenue Share by Country (2021-2032) Figure 68. SAMEA Contraceptive Drugs and Devices Sales Share by Country (2021-2032) Figure 69. Contraceptive Drugs and Devices Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Contraceptive Drugs and Devices Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Contraceptive Drugs
  • Vaginal
  • Male/Female Contraceptive Devices
  • Oral
Applications
  • Hospitals
  • Pharmacies
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Merck
  • Pfizer
  • Bayer Healthcare
  • Warmer Chilcott
  • Pantarhei Bioscience
  • Mayer Laboratories
  • Church & Dwight
  • BioSante Pharmaceuticals
  • Agile Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Contraceptive Drugs and Devices Market by Type
  3. 1.2.1 Global Contraceptive Drugs and Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injectable Contraceptive Drugs
  5. 1.2.3 Vaginal
  6. 1.2.4 Male/Female Contraceptive Devices
  7. 1.2.5 Oral
  8. 1.3 Contraceptive Drugs and Devices Market by Application
  9. 1.3.1 Global Contraceptive Drugs and Devices Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Pharmacies
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Contraceptive Drugs and Devices Market Dynamics
  1. 2.1 Contraceptive Drugs and Devices Industry Trends
  2. 2.2 Contraceptive Drugs and Devices Industry Drivers
  3. 2.3 Contraceptive Drugs and Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drugs and Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Contraceptive Drugs and Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Contraceptive Drugs and Devices Revenue by Region
  3. 3.2.1 Global Contraceptive Drugs and Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Contraceptive Drugs and Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Contraceptive Drugs and Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Contraceptive Drugs and Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Contraceptive Drugs and Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Contraceptive Drugs and Devices Sales by Region
  9. 3.4.1 Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Contraceptive Drugs and Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Contraceptive Drugs and Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Contraceptive Drugs and Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers
  2. 4.1.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Contraceptive Drugs and Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Contraceptive Drugs and Devices Sales by Manufacturers
  6. 4.2.1 Global Contraceptive Drugs and Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Contraceptive Drugs and Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Contraceptive Drugs and Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Contraceptive Drugs and Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Contraceptive Drugs and Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Contraceptive Drugs and Devices Manufacturers, Product Type & Application
  13. 4.7 Global Contraceptive Drugs and Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Contraceptive Drugs and Devices Market CR5 and HHI
  16. 4.8.2 2025 Contraceptive Drugs and Devices Tier 1, Tier 2, and Tier 3
5 Contraceptive Drugs and Devices Market by Type
  1. 5.1 Global Contraceptive Drugs and Devices Revenue by Type
  2. 5.1.1 Global Contraceptive Drugs and Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Contraceptive Drugs and Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Contraceptive Drugs and Devices Sales by Type
  6. 5.2.1 Global Contraceptive Drugs and Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contraceptive Drugs and Devices Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Contraceptive Drugs and Devices Price by Type
6 Contraceptive Drugs and Devices Market by Application
  1. 6.1 Global Contraceptive Drugs and Devices Revenue by Application
  2. 6.1.1 Global Contraceptive Drugs and Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Contraceptive Drugs and Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Contraceptive Drugs and Devices Sales by Application
  6. 6.2.1 Global Contraceptive Drugs and Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Contraceptive Drugs and Devices Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Contraceptive Drugs and Devices Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries
  2. 7.1.1 Teva Pharmaceutical Industries Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Bayer Healthcare
  20. 7.4.1 Bayer Healthcare Company Information
  21. 7.4.2 Bayer Healthcare Business Overview
  22. 7.4.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
  24. 7.4.5 Bayer Healthcare Recent Developments
  25. 7.5 Warmer Chilcott
  26. 7.5.1 Warmer Chilcott Company Information
  27. 7.5.2 Warmer Chilcott Business Overview
  28. 7.5.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
  30. 7.5.5 Warmer Chilcott Recent Developments
  31. 7.6 Pantarhei Bioscience
  32. 7.6.1 Pantarhei Bioscience Company Information
  33. 7.6.2 Pantarhei Bioscience Business Overview
  34. 7.6.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
  36. 7.6.5 Pantarhei Bioscience Recent Developments
  37. 7.7 Mayer Laboratories
  38. 7.7.1 Mayer Laboratories Company Information
  39. 7.7.2 Mayer Laboratories Business Overview
  40. 7.7.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
  42. 7.7.5 Mayer Laboratories Recent Developments
  43. 7.8 Church & Dwight
  44. 7.8.1 Church & Dwight Company Information
  45. 7.8.2 Church & Dwight Business Overview
  46. 7.8.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
  48. 7.8.5 Church & Dwight Recent Developments
  49. 7.9 BioSante Pharmaceuticals
  50. 7.9.1 BioSante Pharmaceuticals Company Information
  51. 7.9.2 BioSante Pharmaceuticals Business Overview
  52. 7.9.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
  54. 7.9.5 BioSante Pharmaceuticals Recent Developments
  55. 7.10 Agile Therapeutics
  56. 7.10.1 Agile Therapeutics Company Information
  57. 7.10.2 Agile Therapeutics Business Overview
  58. 7.10.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
  60. 7.10.5 Agile Therapeutics Recent Developments
8 North America
  1. 8.1 North America Contraceptive Drugs and Devices Market Size by Type
  2. 8.1.1 North America Contraceptive Drugs and Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Contraceptive Drugs and Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Contraceptive Drugs and Devices Price by Type (2021-2032)
  5. 8.2 North America Contraceptive Drugs and Devices Market Size by Application
  6. 8.2.1 North America Contraceptive Drugs and Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Contraceptive Drugs and Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Contraceptive Drugs and Devices Price by Application (2021-2032)
  9. 8.3 North America Contraceptive Drugs and Devices Market Size by Country
  10. 8.3.1 North America Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Contraceptive Drugs and Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Contraceptive Drugs and Devices Market Size by Type
  2. 9.1.1 Europe Contraceptive Drugs and Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Contraceptive Drugs and Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Contraceptive Drugs and Devices Price by Type (2021-2032)
  5. 9.2 Europe Contraceptive Drugs and Devices Market Size by Application
  6. 9.2.1 Europe Contraceptive Drugs and Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Contraceptive Drugs and Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Contraceptive Drugs and Devices Price by Application (2021-2032)
  9. 9.3 Europe Contraceptive Drugs and Devices Market Size by Country
  10. 9.3.1 Europe Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Contraceptive Drugs and Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Contraceptive Drugs and Devices Market Size by Type
  2. 10.1.1 China Contraceptive Drugs and Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Contraceptive Drugs and Devices Sales by Type (2021-2032)
  4. 10.1.3 China Contraceptive Drugs and Devices Price by Type (2021-2032)
  5. 10.2 China Contraceptive Drugs and Devices Market Size by Application
  6. 10.2.1 China Contraceptive Drugs and Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Contraceptive Drugs and Devices Sales by Application (2021-2032)
  8. 10.2.3 China Contraceptive Drugs and Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Contraceptive Drugs and Devices Market Size by Type
  2. 11.1.1 Asia Contraceptive Drugs and Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Contraceptive Drugs and Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Contraceptive Drugs and Devices Price by Type (2021-2032)
  5. 11.2 Asia Contraceptive Drugs and Devices Market Size by Application
  6. 11.2.1 Asia Contraceptive Drugs and Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Contraceptive Drugs and Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Contraceptive Drugs and Devices Price by Application (2021-2032)
  9. 11.3 Asia Contraceptive Drugs and Devices Market Size by Country
  10. 11.3.1 Asia Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Contraceptive Drugs and Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Contraceptive Drugs and Devices Market Size by Type
  2. 12.1.1 SAMEA Contraceptive Drugs and Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Contraceptive Drugs and Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Contraceptive Drugs and Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Contraceptive Drugs and Devices Market Size by Application
  6. 12.2.1 SAMEA Contraceptive Drugs and Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Contraceptive Drugs and Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Contraceptive Drugs and Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Contraceptive Drugs and Devices Market Size by Country
  10. 12.3.1 SAMEA Contraceptive Drugs and Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Contraceptive Drugs and Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Contraceptive Drugs and Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Contraceptive Drugs and Devices Value Chain Analysis
  2. 13.1.1 Contraceptive Drugs and Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Contraceptive Drugs and Devices Production Mode & Process
  6. 13.2 Contraceptive Drugs and Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Contraceptive Drugs and Devices Distributors
  9. 13.2.3 Contraceptive Drugs and Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst